Nov 5 (Reuters) - GlaxoSmithKline Plc
* Regulatory submissions for mepolizumab
* Submissions filed in USA and Europe for anti-il5 monoclonal antibody
* Regulatory filings in other countries are planned during course of 2014 and 2015. Source text for Eikon: Further company coverage: (Reporting by Ben Hirschler)
* Regulatory submissions for mepolizumab
* Submissions filed in USA and Europe for anti-il5 monoclonal antibody
* Regulatory filings in other countries are planned during course of 2014 and 2015. Source text for Eikon: Further company coverage: (Reporting by Ben Hirschler)
via Smart Health Shop Forum http://ift.tt/10m71z2
No comments:
Post a Comment